MediWound Ltd.

IPO

MediWound Ltd. is a biotech company in Yavne, Israel, founded in 2000.

Home - Mediwound

Headquarters
Yavne
Employees
51–200
Founded
2000
Business Model
B2B
Type
Public

Indexed holds 1 investor for this company. The full record is or through the API.

About

MediWound develops and commercializes next-generation enzymatic therapeutics for non-surgical tissue repair. Its therapies selectively remove non-viable hazardous tissue while preserving healthy tissue, offering alternatives to traditional surgical interventions for wound and burn care. The company integrates research, development, sterile manufacturing, and commercialization, with NexoBrid used for severe burns and EscharEx advancing for chronic wounds.

Summary

It lists 51–200 employees. Investors include Mölnlycke Health Care.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

Data from Indexed.vcUpdated
Post-IPO EquityRegistered Direct OfferingSep 2025
$30.0M

Sign up to see all 3 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MediWound Ltd. on Indexed.vc
<a href="https://indexed.vc/companies/mediwound-ltd"><img src="https://indexed.vc/api/badge/company/mediwound-ltd" alt="MediWound Ltd. on Indexed.vc" width="260" height="76" /></a>